Trials / Sponsors / Stanley Jordan, MD
Stanley Jordan, MD
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy | Phase 1 / Phase 2 | 2018-02-27 |
| Completed | Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy | Phase 1 / Phase 2 | 2018-02-21 |
| Completed | Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased End Stage Renal Disease | Phase 1 / Phase 2 | 2013-09-01 |
| Completed | Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection Kidney Transplantation | Phase 1 / Phase 2 | 2011-08-01 |